Lyvispah Granule
Product Images NDC 64896-078

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lyvispah (NDC 64896-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Lyvispah Baclofen Oral Granules 1)

Chem Structure (Lyvispah Baclofen Oral Granules 1)
Chemical structure of baclofen showing a chlorophenyl group attached to a carbon connected to an amino group and a carboxylic acid group, consistent with the active ingredient in LYVISPAH oral granules.*
FDA Label Image

Ifu Image 1 (Lyvispah Baclofen Oral Granules 2)

Ifu Image 1 (Lyvispah Baclofen Oral Granules 2)
Label for LYVISPAH (baclofen) oral granules showing the brand name and generic name. The label includes instructions to use scissors to open at a perforated line. No strength or other packaging details are visible.*
FDA Label Image

5mg Ifc (Lyvispah Baclofen Oral Granules 3)

5mg Ifc (Lyvispah Baclofen Oral Granules 3)
LYVISPAH 5 mg baclofen oral granules carton packaging label. The label includes dosage instructions, warnings about keeping out of reach of children, storage information, and the statement that the carton contains 90 individual packets for oral administration. The labeler is Amneal Pharmaceuticals LLC, and the design features green and purple colors with Rx Only designation and NDC 64896-076-09.*
FDA Label Image

10mg Ifc (Lyvispah Baclofen Oral Granules 4)

10mg Ifc (Lyvispah Baclofen Oral Granules 4)
Packaging label for LYVISPAH baclofen oral granules 10 mg, distributed by Amneal Pharmaceuticals LLC. The label includes the product name, strength, dosage form, directions for use, caution statements, storage conditions, and an NDC number (64896-077-09). The design features blue and white colors with wave graphics, and it contains 90 individual packets for oral administration.*
FDA Label Image

20mg Ifc (Lyvispah Baclofen Oral Granules 5)

20mg Ifc (Lyvispah Baclofen Oral Granules 5)
LYVISPAH 20 mg oral granules packaging label for baclofen granules by Amneal Pharmaceuticals LLC. The label features orange and white colors, highlighting the 20 mg strength prominently. It includes instructions for use, warnings to keep out of reach of children, storage information, and states the package contains 90 individual packets for oral administration. The label shows the drug is Rx only and includes barcodes and lot/expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.